Loading data
OPTUNYSE
| Unit: USD | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 8.59 bn USD | 8.95 bn USD | 9.24 bn USD | 9.65 bn USD | 10.09 bn USD |
| Cost of revenue | 2.64 bn USD | 2.9 bn USD | 3.03 bn USD | 3.21 bn USD | 3.38 bn USD |
| Research and development expense | — | — | 33.43 m USD | 22.29 m USD | — |
| Operating profit | -112.56 m USD | 1.68 bn USD | 1.7 bn USD | 1.8 bn USD | 2.52 bn USD |
| Profit before tax | -1.93 bn USD | -82.35 m USD | 118.57 m USD | 516.73 m USD | 1.31 bn USD |
| Income tax expense | -96.91 m USD | -4.07 m USD | 39.53 m USD | 295.84 m USD | 294.98 m USD |
| Net income (reported basis) | -1.83 bn USD | -78.28 m USD | 79.04 m USD | 220.89 m USD | 1.01 bn USD |
| Basic earnings per share | -4 USD/share | -0.22 USD/share | 0.12 USD/share | 0.43 USD/share | 2.16 USD/share |
| Diluted earnings per share | -4 USD/share | -0.22 USD/share | 0.12 USD/share | 0.43 USD/share | 2.14 USD/share |
Quotes are end-of-day data. Content is for research purposes and is not investment advice.